Skip to main content
Clinical Trials/NCT07343466
NCT07343466
Recruiting
Not Applicable

Klinische Studie Zur Untersuchung Der Lebensqualität Und Des Einflusses Von Stress Auf Den Postoperativen Verlauf Von Patienten Nach Device-Implantation

University Hospital, Essen1 site in 1 country300 target enrollmentStarted: February 4, 2025Last updated:

Overview

Phase
Not Applicable
Status
Recruiting
Sponsor
University Hospital, Essen
Enrollment
300
Locations
1
Primary Endpoint
Cumulative incidence of device-related complications

Overview

Brief Summary

The project "Investigating Quality of Life and the Influence of Stress on the Postoperative Course of Patients After Device Implantation" aims to investigate the relationship between stress and the postoperative healing process of patients who have had a medical device implanted. These devices include pacemakers for the treatment of bradycardia, implantable cardioverter-defibrillators (ICDs) for the treatment of tachycardia in primary and secondary prevention, and cardiac resynchronization therapy (CRT) devices and event recorders. The study will analyze the influence of stress on the postoperative course, potential complications, and overall quality of life. A combination of medical examinations and surveys will be used to analyze how psychological stress influences the physical healing process and which measures can contribute to improving quality of life and treatment success. The surgical procedure for implanting devices is not part of the study; this is an observational study.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients of legal capacity with an indication for device implantation (pacemaker, ICD, CRT, event recorder) who present at the Department of Cardiology and Angiology at the University Hospital Essen and consent to participate in the study will be included.

Exclusion Criteria

  • Not provided

Arms & Interventions

Patients with indication for device implantation (pacemaker, ICD, CRT, event recorder)

Patients with cardiac diseases, that makes a device implantation (pacemaker, ICD, CRT, event recorder) necessary, including primary and secondary indication for an ICD.

Intervention: Survey using a questionnaire. (Other)

Outcomes

Primary Outcomes

Cumulative incidence of device-related complications

Time Frame: 36 Months

Measures the incidence of device-related complications, this includes: Complications related to Device- pockets, leads and infections connected to the devices

Secondary Outcomes

  • hospitalisation rate(36 Months)
  • Number of participants with the following arrhythmic events: ventrikular tachykardia and ventrikular fibrillation(Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months)
  • Changes in functional capacity(Baseline (at 4-6 weeks) , after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months)
  • combined global stress measure(Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months)
  • Health-related quality of life - SF-36(Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months)
  • Health-related Quality of life - EQ-5D-5L(Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months)
  • Health-related Quality of life - VAS for general health(Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months)
  • Depression symptoms (BDI-II)(Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months)
  • Anxiety symptoms (STAI)(Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months)
  • PROMIS-Anger Scale(Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months)
  • GHQ, Evaluation of distress(Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months)
  • Perceived Stress Scale(Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months)
  • Appropriate vs. inappropriate Shocks(Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months)
  • proinflammatory mediators- IL6(Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months)
  • Proinflammatory mediators - CRP(Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months)
  • Proinflammatory mediators- PCT(Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months)

Investigators

Sponsor
University Hospital, Essen
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials